(Q46576710)

English

A 52-week placebo-controlled trial of evolocumab in hyperlipidemia

scientific article published on 29 March 2014

In more languages
default for all languages
No label defined

No description defined

Statements

A 52-week placebo-controlled trial of evolocumab in hyperlipidemia (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit